Market open
Inspire Medical Systems/$INSP
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Inspire Medical Systems
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Ticker
$INSP
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,246
Website
INSP Metrics
BasicAdvanced
$5.8B
112.35
$1.75
1.32
-
Price and volume
Market cap
$5.8B
Beta
1.32
52-week high
$257.40
52-week low
$123.00
Average daily volume
564K
Financial strength
Current ratio
7.128
Quick ratio
6.086
Long term debt to equity
4.355
Total debt to equity
4.61
Interest coverage (TTM)
1,640.14%
Management effectiveness
Return on assets (TTM)
3.04%
Return on equity (TTM)
8.48%
Valuation
Price to earnings (TTM)
112.349
Price to revenue (TTM)
7.289
Price to book
8.48
Price to tangible book (TTM)
8.48
Price to free cash flow (TTM)
64.218
Growth
Revenue change (TTM)
28.49%
Earnings per share change (TTM)
-342.42%
3-year revenue growth (CAGR)
50.95%
3-year earnings per share growth (CAGR)
4.31%
What the Analysts think about INSP
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Inspire Medical Systems stock.
INSP Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
INSP Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
INSP News
AllArticlesVideos
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Inspire Medical Systems, Inc. (NYSE: INSP) and Encourages Long-Term Inspire Investors to Contact the Firm
GlobeNewsWire·1 week ago
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 weeks ago
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Inspire Medical Systems stock?
Inspire Medical Systems (INSP) has a market cap of $5.8B as of February 27, 2025.
What is the P/E ratio for Inspire Medical Systems stock?
The price to earnings (P/E) ratio for Inspire Medical Systems (INSP) stock is 112.35 as of February 27, 2025.
Does Inspire Medical Systems stock pay dividends?
No, Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders as of February 27, 2025.
When is the next Inspire Medical Systems dividend payment date?
Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders.
What is the beta indicator for Inspire Medical Systems?
Inspire Medical Systems (INSP) has a beta rating of 1.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.